Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
VANCOUVER, British Columbia and WARMINSTER, Pa., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading hepatitis B virus (HBV) therapeutic solutions...
-
Toronto, Sept. 07, 2017 (GLOBE NEWSWIRE) -- While a parent’s back-to-school list is dominated with purchasing new school clothes, backpacks and school supplies, the Eye Physicians and Surgeons of...
-
CALGARY, AB--(Marketwired - September 07, 2017) - Alberta -- once Canada's leader in fiscal management -- has become a laggard along with Ontario, finds a new study released today by the Fraser...
-
BETHLEHEM, Pa., Sept. 06, 2017 (GLOBE NEWSWIRE) -- B. Braun Medical Inc., a market leader in regional anesthesia, will present its innovative line of Regional Anesthesia products at the American...
-
CALGARY, AB--(Marketwired - September 06, 2017) - On Thursday, Sept. 7, the Fraser Institute will release a new study on Alberta's provincial government finances.Canada's Past Fiscal Leaders Now...
-
BEDMINSTER, N.J., and DUBLIN, Ireland, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of...
-
CALGARY, AB--(Marketwired - September 06, 2017) - Per-student spending in Alberta public schools increased nearly 18 per cent over the past decade, with the vast majority of all increased spending...
-
LAGUNA HILLS, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Sonendo®, Inc., the developer of a breakthrough technology for the dental marketplace, the GentleWave® System, today announced that Bjarne...
-
EXTON, Pa., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective...
-
Key Updates ProQR’s drug candidate QRX-421 for Usher syndrome receives orphan drug designation from the FDA and EMA, representing the third candidate in the company’s ophthalmology pipeline and the...